Top 5 Companies Advertising in Professional Health Journals (Dollars) through April 2013

by Client Services

Johnson & Johnson continues to be the top pharma company advertising in professional health journals by dollars, according to Kantar Media. Johnson & Johnson is the parent company of Janssen Pharmaceuticals, which markets Xarelto. Through April, Xarelto is the top drug advertised in professional health journals by dollars with $5 million.

Other companies making big investments in print journal advertising are as follows:

Top 5 Print Ad Pharma Companies (Dollars): Jan. – April 2013

#1 Johnson & Johnson– $11 MM (+32%)

#2 Forest Laboratories – $6 MM (-70%)

#3 Pfizer – $5 MM (+4%)

#4 Ironwood Pharmaceutical and Forest Pharmaceuticals – $4 MM (N/A)

#5 Novartis – $3 MM (+28%)

Novartis did not make the list for top 5 companies advertising in professional health journals last month. It markets the product Afinitor, which is used to treat certain types of kidney cancer, breast cancer or brain tumors.

The percentage changes compare January – April 2013 to that same time period in 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.